Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0


Archives de pédiatrie
Volume 12, n° 6
pages 755-757 (juin 2005)
Doi : 10.1016/j.arcped.2005.03.014
Purpura fulminans : qu'apportent les traitements hormonaux et hémostatiques ?
Purpura fulminans : what do hormonal and haemostatic treatments add?
 

F. Leclerc , A. Sadik, A. Binoche, O. Noizet
Service de réanimation pédiatrique, hôpital Jeanne-de-Flandre, CHU de Lille, Lille, France 

*Auteur correspondant.

Mots clés : Purpura fulminans , Choc septique, Traitements hémostatiques, Traitements hormonaux

Keywords : Purpura fulminans , Septic shock, Haemostatic treatments, Hormonal treatments


1  Au vu des résultats de l'analyse intermédiaire effectuée le 8 mars 2005 sur 400 patients, le Comité de surveillance des données a recommandé d'interrompre l'essai pour son manque de puissance prévisible à démontrer un rapport bénéfice/risque favorable de la Drotrécogine Alpha (activée).


© 2005  Elsevier SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline